Axon Enterprise, Inc (NASDAQ:AXON) Shares Acquired by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 0.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 554,382 shares of the biotechnology company's stock after acquiring an additional 3,185 shares during the period. Massachusetts Financial Services Co. MA owned 0.71% of Axon Enterprise worth $291,577,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Brighton Jones LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $480,000. EverSource Wealth Advisors LLC raised its position in shares of Axon Enterprise by 12.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 311 shares of the biotechnology company's stock worth $185,000 after purchasing an additional 34 shares during the period. Frank Rimerman Advisors LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth approximately $286,000. Natixis Advisors LLC raised its position in shares of Axon Enterprise by 2.8% during the fourth quarter. Natixis Advisors LLC now owns 31,251 shares of the biotechnology company's stock worth $18,573,000 after purchasing an additional 859 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in Axon Enterprise by 0.8% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 4,900 shares of the biotechnology company's stock worth $2,912,000 after buying an additional 41 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

NASDAQ:AXON traded down $4.39 during mid-day trading on Tuesday, hitting $745.87. 373,385 shares of the company traded hands, compared to its average volume of 706,048. The firm has a market cap of $58.07 billion, a price-to-earnings ratio of 180.16, a price-to-earnings-growth ratio of 83.99 and a beta of 1.29. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The stock's fifty day moving average price is $752.67 and its 200-day moving average price is $641.14. Axon Enterprise, Inc has a one year low of $279.02 and a one year high of $830.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The company had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same period in the prior year, the company earned $1.15 earnings per share. The firm's revenue was up 31.3% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Michael Garnreiter sold 5,913 shares of the stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the sale, the director owned 17,740 shares of the company's stock, valued at approximately $13,482,400. This trade represents a 25.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of the stock in a transaction on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the sale, the chief accounting officer directly owned 15,240 shares in the company, valued at $11,762,384.40. This trade represents a 0.49% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 44,642 shares of company stock valued at $30,500,428. Company insiders own 5.70% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AXON. Barclays increased their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Bank of America raised their price objective on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the company an "overweight" rating in a report on Friday. Wolfe Research began coverage on Axon Enterprise in a research report on Monday, July 7th. They set an "outperform" rating on the stock. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average price target of $716.36.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.